Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Active not recruiting × Tislelizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 105 Neoplasms 74 Breast Neoplasms 72 Melanoma 68 Leukemia, Myeloid, Acute 57 Neoplasm Metastasis 56 Lymphoma, Non-Hodgkin 50 Glioblastoma 50 Colorectal Neoplasms 50 Lung Neoplasms 49 Ovarian Neoplasms 48 Recurrence 45 Multiple Myeloma 45 Prostatic Neoplasms 44 Pancreatic Neoplasms 43 Carcinoma, Renal Cell 41 Squamous Cell Carcinoma of Head and Neck 39 Leukemia, Lymphocytic, Chronic, B-Cell 32 Brain Neoplasms 32 Triple Negative Breast Neoplasms 29 Myelodysplastic Syndromes 28 Glioma 28 Stomach Neoplasms 27 Lymphoma 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, B-Cell 26 Lymphoma, Follicular 22 Leukemia 22 Carcinoma, Hepatocellular 21

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906044 2023-11-18

STARS-RC03

The First Hospital of Jilin University

Phase 1 Active not recruiting

Gastrointestinal

Tislelizumab

Data powered by HemOnc (CC BY 4.0) Colophon ⚡